A detailed history of Barton Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Barton Investment Management holds 9,614 shares of ABBV stock, worth $1.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
9,614
Previous 9,614 -0.0%
Holding current value
$1.9 Million
Previous $1.75 Million 5.83%
% of portfolio
0.22%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $66,606 - $84,276
620 Added 6.89%
9,614 $1.3 Million
Q1 2018

Apr 18, 2018

BUY
$92.01 - $123.21 $827,537 - $1.11 Million
8,994 New
8,994 $851,000
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $827,537 - $1.11 Million
-8,994 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $628,230 - $802,444
8,994
8,994 $799,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Barton Investment Management Portfolio

Follow Barton Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barton Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Barton Investment Management with notifications on news.